Seeking Alpha

Medical products supplier Abaxis (ABAX +16%) pops after its FQ2 easily beats estimates. Revenues...

Medical products supplier Abaxis (ABAX +16%) pops after its FQ2 easily beats estimates. Revenues rose 13% Y/Y on a jump in veterinary product and medical instrument sales, plus solid growth in its European and Asian markets. Separately, the company also approves $40M stock buyback program.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|